New offering helps health systems strengthen financial confidence, operational readiness and program scalability to support broader patient access to cell and gene therapies.
Helping pharmacies innovate and improve their performance.
Recognition from J.D. Power coincides with ThoughtSpot, Cencora’s flagship annual tradeshow and conference for community care providers.
Ken Hardy will help lead the foundation's efforts to enhance healthcare access and strengthen pharmaceutical supply chains in disaster-affected and underserved communities around the globe.
The solution reflects continued investment in workflow efficiency, data visibility and practice performance.
Collaboration aims to facilitate efficient access to therapies as Kite expands treatment center network.
Hohman and Weber to focus on innovation, performance.
Cencora reaffirms fiscal 2026 financial guidance.
James Cleary to retire as CFO effective June 30.
Expanded capabilities in Europe and the United States enable company to deliver enhanced third-party logistics support to pharmaceutical companies.
The investments, including opening of a second national distribution center, support a more resilient and efficient pharmaceutical supply chain.
The lawsuit brought by pension funds accused Cencora’s leadership of ignoring red flags around how the company was dispensing the highly addictive painkillers for years — including dubiously large opioid shipments — and failing to properly monitor opioid sales.
A highlight was the presentation of the 2025 Good Neighbor Pharmacy Champion Awards, recognizing three member pharmacies for leadership in advocacy, clinical care, and patient engagement.
Cencora remains committed to ensuring life-saving therapies are delivered efficiently and reliably to those who need them most.
Marketplace program helps pharmacies drive front-end business.
Event to highlight breadth of innovative capabilities, solutions and strategic partnerships that support healthcare continuum.
